2022
DOI: 10.2147/jir.s364877
|View full text |Cite
|
Sign up to set email alerts
|

TLR Signaling Pathway Gene Polymorphisms, Gene–Gene and Gene–Environment Interactions in Allergic Rhinitis

Abstract: Background Allergic rhinitis (AR) is a nasal inflammatory disease resulting from a complex interplay between genetic and environmental factors. The association between Toll-like receptor (TLR) signaling pathway and environmental factors in AR pathogenesis remains to be explored. This study aims to assess the genetic association of AR with single nucleotide polymorphisms (SNPs) in TLR signaling pathway, and investigate the roles of gene–gene and gene–environment interactions in AR. M… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 62 publications
0
5
0
Order By: Relevance
“…The controls were recruited from the hospital seeking health care or routine health examinations and were frequency-matched with the cases in age (±5 years) and sex. The selection criteria for controls: 12 , 13 , 21 (1) no symptoms and medical history of AR and nasal diseases; (2) no symptoms and medical history of other allergic diseases, such as asthma, eczema and urticaria; (3) negative blood test for serum allergen-specific IgE in the phadiatop assay (Phadia, Uppsala, Sweden); (4) no history of AR or other allergic diseases in the immediate family. The exclusion criteria for all subjects: (1) complicated with acute upper respiratory tract infection, severe deviation of nasal septum, rhinosinusitis with or without nasal polyps, neoplasms in paranasal sinuses and nasal cavity; (2) combined with other immune diseases and systemic diseases; (3) use of corticosteroids during previous 4 weeks and antihistamines/antileukotrienes during previous 2 weeks.…”
Section: Methodsmentioning
confidence: 99%
“…The controls were recruited from the hospital seeking health care or routine health examinations and were frequency-matched with the cases in age (±5 years) and sex. The selection criteria for controls: 12 , 13 , 21 (1) no symptoms and medical history of AR and nasal diseases; (2) no symptoms and medical history of other allergic diseases, such as asthma, eczema and urticaria; (3) negative blood test for serum allergen-specific IgE in the phadiatop assay (Phadia, Uppsala, Sweden); (4) no history of AR or other allergic diseases in the immediate family. The exclusion criteria for all subjects: (1) complicated with acute upper respiratory tract infection, severe deviation of nasal septum, rhinosinusitis with or without nasal polyps, neoplasms in paranasal sinuses and nasal cavity; (2) combined with other immune diseases and systemic diseases; (3) use of corticosteroids during previous 4 weeks and antihistamines/antileukotrienes during previous 2 weeks.…”
Section: Methodsmentioning
confidence: 99%
“…This study is the first to report the association between TLR2 rs7656411 and AR, although this SNP has been previously associated with asthma in the Chinese population. Notably, the results of studies on TLR2 SNPs and the risk of asthma in different populations are contradictory, and meta-analyses suggest that other SNPs, such as rs4696480 and rs3804099, are associated with asthma ( Chen et al, 2022 ).…”
Section: Genetic Associations Between Tlrs and Allergymentioning
confidence: 99%
“…In the presence of LPS-binding protein (LBP) and CD14, TLR4 binds to LPS with the help of co-receptor myeloid differentiation protein 2 (MD-2) ( 53 , 59 ). The surroundings have an effect on the bond between them ( 60 ). Stimulated activation of TLR4 consists of two major intracellular signaling pathways: the myeloid differentiation primary response 88 (MyD88)-dependent pathway and the toll-interleukin-1 receptor (TIR) structural domain-containing adapter-induced IFN-β (TRIF) pathway ( 54 ).…”
Section: Tlr4/irak4/nf-κb Signaling Pathwaymentioning
confidence: 99%
“…With abundant leucine repeats, TLRs regulate Th1/Th2 immune balance through DCs, mast cells and Tregs ( 52 , 60 ). The adaptive immune response can be skewed toward Th1 by TLRs, which can cause DCs maturation and T cell activation ( 60 ). A variety of inflammatory cytokines and chemokines are released when TLRs activate DCs ( 95 ).…”
Section: Tlr4/irak4/nf-κb Signaling Pathway and Armentioning
confidence: 99%